References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
DockrellandKinghorn(2001)Imiquimodandresiquimodasnovelimmunomodulators.J.Antimicrob.Chemother.48751PMID:11733457
Miyamotoetal(2012)R848,atoll-likereceptor7agonist,inhibitsosteoclastdifferentiationbutnotsurvivalorbone-resorbingfunctionofmatureosteoclasts.Cytotechnology.64331PMID:22358541
Wagneretal(1999)ModulationofTH1andTh4cytokineproductionwiththeimmuneresponsemodifiers,R-848andimiquimod.CellImmunol.19110PMID:9918682
Leeetal(2014)Resiquimod,aTLR7/8agonist,promotesdifferentiationofmyeloid-derivedsuppressorcellsintomacrophagesanddendriticcells.Arch.Pharm.Res.371234PMID:24748512
Keywords:Resiquimod,supplier,proinflammatory,toll,like,receptors,ligands,agonists,TLR7,cytokines,interferons,interleukins,R848,R_848,myeloid-derived,suppressor,cells,MDSCs,tumor,microenvironment,R,848,Toll-like,Receptors,Antivirals,Toll-like,Receptors,TocrisBioscience